drug · gene
olvimulogene nanivacirepvec
Phase 3updated 3mo agoby $GNLX GENELUX Corp🔗 ChEMBL
Phase 3community read0 votes
Gene drug with a maximum clinical stage of Phase 2 (across all indications), with 6 investigational indications.
all catalysts(0)
nothing on the calendar yet
Trials studying olvimulogene nanivacirepvec
- phase3Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
- phase2Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that